SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
28-Mar-24 6:16 PM View: | Gossamer Bio, Inc. (GOSS) | 27-Mar-24 | Sale | 6,430 | $1.16 | $7,429.87 | (< 1%) 660.48K to 654.05K | |
19-Jan-24 9:05 PM View: | AP Pharma Inc. (HRTX) | 19-Jan-24 | Grant | 13,948 | -- | -- | 27% 52.23K to 66.18K | |
26-Jul-23 4:01 PM View: | Gossamer Bio, Inc. (GOSS) | 24-Jul-23 | Grant | 13,504 | $1.82 | $24,577.30 | 2% 637.09K to 650.59K | |
22-Mar-23 5:19 PM View: | Gossamer Bio, Inc. (GOSS) | 20-Mar-23 | Private Purchase | 18,500 | $1.20 | $22,144.50 | 3% 618.59K to 637.09K | |
20-Dec-22 5:22 PM View: | AP Pharma Inc. (HRTX) | 16-Dec-22 | Grant | 38,580 | -- | -- | 283% 13.65K to 52.23K | |
15-Jul-22 4:25 PM View: | Gossamer Bio, Inc. (GOSS) | 15-Jul-22 | Private Purchase Duplicate | 6,934 | $7.21 | $49,994.10 | 1% 608.18K to 615.12K | |
24-Mar-22 4:57 PM View: | Gossamer Bio, Inc. (GOSS) | 23-Mar-22 | Sale | 10,722 | $8.91 | $95,586.60 | (2%) 618.91K to 608.18K | |
23-Dec-21 6:58 PM View: | AP Pharma Inc. (HRTX) | 22-Dec-21 | Grant | 10,452 | -- | -- | 327% 3.2K to 13.65K | |
23-Dec-21 6:58 PM View: | AP Pharma Inc. (HRTX) | 21-Dec-21 | Sale (Planned) | 300 | $9.73 | $2,920.35 | (9%) 3.5K to 3.2K | |
23-Sep-21 10:00 PM View: | AP Pharma Inc. (HRTX) | 21-Sep-21 | Sale (Planned) | 300 | $12.31 | $3,691.95 | (8%) 3.8K to 3.5K | |
22-Jun-21 5:06 PM View: | AP Pharma Inc. (HRTX) | 21-Jun-21 | Sale (Planned) | 300 | $15.20 | $4,559.19 | (7%) 4.1K to 3.8K | |
16-Apr-21 10:00 PM View: | AP Pharma Inc. (HRTX) | 15-Apr-21 | Market Sale (Planned) | 300 | $17.51 | $5,253.78 | (7%) 4.4K to 4.1K | (< 1%) |
25-Mar-21 10:00 PM View: | Gossamer Bio, Inc. (GOSS) | 23-Mar-21 | Market Sale | 5,490 | $9.48 | $52,050.70 | (< 1%) 622.87K to 617.38K | 8% |
01-Mar-21 4:37 PM View: | Gossamer Bio, Inc. (GOSS) | 25-Feb-21 | Grant | 45,000 | -- | -- | 8% 577.87K to 622.87K | |
23-Dec-20 4:21 PM View: | AP Pharma Inc. (HRTX) | 21-Dec-20 | Grant | 3,000 | -- | -- | 214% 1.4K to 4.4K | |
14-Oct-20 7:29 PM View: | Gossamer Bio, Inc. (GOSS) | 14-Oct-20 | Market Purchase | 2,500 | $9.53 | $23,818.00 | < 1% 574.67K to 577.17K | 8% |
19-Feb-20 4:21 PM View: | Gossamer Bio, Inc. (GOSS) | 14-Feb-20 | Grant | 46,500 | -- | -- | 9% 528.17K to 574.67K | |
27-Sep-19 10:46 AM View: | Gossamer Bio, Inc. (GOSS) | 27-Sep-19 | Market Purchase | 1,000 | $16.65 | $16,654.20 | < 1% 527.17K to 528.17K | (38%) |
16-May-19 8:44 AM View: | AP Pharma Inc. (HRTX) | 15-May-19 | Market Purchase | 1,400 | $18.04 | $25,261.70 | 100% 0 to 1.4K | < 1% |
12-Feb-19 5:36 PM View: | Gossamer Bio, Inc. (GOSS) | 12-Feb-19 | Conversion | 3,454 | -- | -- | < 1% 522.17K to 525.62K | |
12-Feb-19 5:36 PM View: | Gossamer Bio, Inc. (GOSS) | 12-Feb-19 | Purchase | 1,550 | $16.00 | $24,800.00 | < 1% 525.62K to 527.17K | |
27-Aug-15 6:27 PM View: | Receptos, Inc. (RCPT) | 27-Aug-15 | Disposition | 9,500 | -- | -- | (100%) 9.5K to 0 | |
05-May-15 9:00 PM View: | Receptos, Inc. (RCPT) | 01-May-15 | Option Exercise | 12,500 | $22.65 | $283,125.00 | 100% 0 to 12.5K | |
05-May-15 9:00 PM View: | Receptos, Inc. (RCPT) | 01-May-15 | Market Option Sale (Planned) | 12,500 | $154.46 | $1,930,750.00 | (100%) 12.5K to 0 | (50%) |
03-Apr-15 9:01 PM View: | Receptos, Inc. (RCPT) | 01-Apr-15 | Grant | 9,500 | -- | -- | 100% 0 to 9.5K | |
20-Jan-15 9:00 PM View: | Receptos, Inc. (RCPT) | 16-Sep-14 | Option Exercise | 25,000 | $22.65 | $566,250.00 | 100% 0 to 25.0K | |
20-Jan-15 9:00 PM View: | Receptos, Inc. (RCPT) | 16-Sep-14 | Planned Private Option Sale | 25,000 | $107.05 | $2,676,250.00 | (100%) 25.0K to 0 | |
27-Jun-13 7:56 PM View: | Websense, Inc. (WBSN) | 25-Jun-13 | Grant | 5,250 | -- | -- | 135% 3.89K to 9.14K | |
27-Jun-13 7:56 PM View: | Websense, Inc. (WBSN) | 25-Jun-13 | Disposition | 9,137 | -- | -- | (100%) 9.14K to 0 | |
12-Feb-13 5:22 PM View: | Websense, Inc. (WBSN) | 10-Feb-13 | Grant | 3,500 | $0.01 | $35.00 | 100% 0 to 3.5K |